4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000174
EVP, Chief Technical Ops. Off. sold 7,288 shares at $478.00 ($3,483,664)
- EVP, Chief Technical Ops. Off. gave up 6,824 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-11 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −6,824 | $481.96 | $3,288,895 | 23,260 | D |
| 2024-06-12 | Sale : show line 2 in the form 10b5-1 | −7,288 | $478.00 | $3,483,664 | 15,972 | D |
| Open-market sales · 7,288 sh · avg $478.00 · $3,483,664 | ||||||
Loading xslF345X05/wk-form4_1718309345.xml…